Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Overall, the open-label phase 1/2 study is assessing the safety and anti-tumor activity with INKmune across 3 dose levels. “The key here is I don’t believe that testosterone increases the risk of ...

Jaiprakash Associates Ltd., incorporated in the year 1995, is a Small Cap company (having a market cap of Rs 1,141.39 Crore) operating in Diversified sector. Jaiprakash Associates Ltd. key ...

These interconnections underscore the necessity for comprehensive research into the metabolic and immunological underpinnings of urological cancers. This Research Topic aims to decipher the complex ...

Jaiprakash Associates Disclosure Of Defaults On Payment Of Interest/Repayment Of Principal Amount On Loans From Banks/Financial Institutions-Q ...